TickerFactsScreenerDevelopers

Aldeyra Therapeutics, Inc. (ALDX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$3.68M2014: -$7.27M2015: -$11.99M2016: -$18.70M2017: -$22.49M2018: -$39.70M2019: -$63.07M2020: -$36.42M2021: -$56.22M2022: -$62.68M2023: -$42.79M2024: -$60.12M2025: -$35.27M-$35.27M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$35.27M+41.3%
2024-$60.12M-40.5%
2023-$42.79M+31.7%
2022-$62.68M-11.5%
2021-$56.22M-54.4%
2020-$36.42M+42.3%
2019-$63.07M-58.9%
2018-$39.70M-76.5%
2017-$22.49M-20.3%
2016-$18.70M-55.9%
2015-$11.99M-64.9%
2014-$7.27M-97.8%
2013-$3.68M—